Ischemic Stroke clinical trials

Explore recruiting ischemic stroke clinical trials.

Recruiting ischemic stroke studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ischemic Stroke trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

Latvia, Italy, Estonia, Czechia, Finland, Netherlands +16 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Double-blind, Randomized,Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a)

Spain, Hungary, Portugal, Greece, Germany, Italy +11 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impactof Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)

Slovakia, Denmark, Portugal, Czechia, Poland, Greece +12 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Belgium, Czechia, Poland, France, Finland, Portugal +16 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE)

Spain, Germany, Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Multicentre Randomized trial of Ghrelin in anterior circulation ischemic stroke treated with endovascular thrombectomy. A randomized phase 2 trial.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Ischemic Stroke trials by city

Ischemic Stroke in Toronto Ischemic Stroke in Vancouver Ischemic Stroke in Montreal Ischemic Stroke in Calgary Ischemic Stroke in Edmonton Ischemic Stroke in Ottawa Ischemic Stroke in Winnipeg Ischemic Stroke in Quebec City Ischemic Stroke in Hamilton Ischemic Stroke in Kitchener Ischemic Stroke in London Ischemic Stroke in Halifax Ischemic Stroke in New York Ischemic Stroke in Los Angeles Ischemic Stroke in Chicago Ischemic Stroke in Houston

Ischemic Stroke clinical trials

Recruiting ischemic stroke studies right now

Implementation of IVS3 for Upper Limb Motor Recovery

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2

A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment

The Fourth Left Atrial Appendage Occlusion Study

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy

Thrombolysis in Factor Xa-inhibitors Trial

Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.

HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke

Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke

Evaluation and Prediction of the Effect of EECP on HR-NICE Patients

A Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patients Suffering from Cardio-neurovascular Pathology and to Those Involved in the Action.

Also recruiting in Europe

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

A Double-blind, Randomized,Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a)

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impactof Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE)

Multicentre Randomized trial of Ghrelin in anterior circulation ischemic stroke treated with endovascular thrombectomy. A randomized phase 2 trial.

Ischemic Stroke trials by city

Other conditions